Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Melanoma Management|September 8, 2018
Targeting immune checkpoints in melanoma: an updateRodrigo R Munhoz, Alejandro Falcón González, Vanessa A Reed, et al.
Cancers|March 11, 2023
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx StudyAntonio Llombart-Cussac, Antonio Anton-Torres, Beatriz Rojas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2024
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patientsAlejandro Falcón González, María Isabel Gallegos Sancho, Encarnación González Flores, et al.
JNCI Cancer Spectrum|April 16, 2024
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrationsAndrea Necchi, Rodryg Ramlau, Alejandro Falcón González, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 28, 2024
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR studyAlejandro Falcón González, Josefina Cruz Jurado, Elisenda Llabrés Valenti, et al.
Frontiers in Oncology|March 12, 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern SpainAlejandro Falcón-González, Elisenda Llabrés-Valenti, Fernando Henao-Carrasco, et al.
Pageof 1